臨床婦人科産科64巻3号

2010年03月発行

今月の臨床 子宮頸がんの予防戦略―ワクチンと検診 HPVワクチン─確実な予防効果

1．子宮頸がんは予防すべき「がん」である

著者： 小西郁生¹

所属機関： ¹京都大学大学院医学研究科婦人科学産科学

ページ範囲：P.242 - P.245

はじめに

　2009年10月16日，わが国においても，ついにヒトパピローマウイルス（human papillomavirus : HPV）の感染を予防するワクチンが正式承認された．このことにより子宮頸がんの発生原因であるHPVの60～70％を占める16型および18型の感染を防ぐことが可能となり，このワクチン接種と従来からの子宮頸がん検診の両方を押し進めることにより，わが国において，あるいはこの地球上で，子宮頸がんの発生を限りなくゼロに近づける展望が開けてきたといえる．そこで，本稿では子宮頸がんの原因を探求してきた歴史を振り返りながら，現在，われわれが立っている地点を確認し，近未来における子宮頸がん征圧を展望したい．

参考文献

1）Rigioni-Stern D : Fatti Statistici Relativi Alle Malattie Cancerose. Gior Servire Progr Path Terap 2 : 507-517, 1842

2）Rojel J : The interrelation between uterine cancer and syphilis. Acta Pathol Microbiol Scand 97 : suppl 1-82, 1953

3）Rotkin ID : A comparison review of key epidemiologic studies in cervical cancer related to current searches for transmissible agents. Cancer Res 33 : 1353-1367, 1973

4）Peters RK, Thomas D, Hagan DC, et al : Risk factors for invasive cervical cancer among Latins and non-Latins in Los Angeles Country. J Natl Cancer Inst 77 : 1063-1077, 1986

5）Vineberg HN : The etiology of cancer of the pelvic organ. Am J Obstet 53 : 410-419, 1906

6）Ferenczy A : Cervical intraepithelial neoplasia. In : Pathology of the Female Genital Tract, 2nd ed（Blaustein A, ed）. pp156-177, Springer-Verlag, New York, 1984

7）Rawls WE, Gardner HL, Kaufman RL : Antibodies to genital herpesvirus in patients with carcinoma of the cervix. Am J Obstet Gynecol 107 : 710-716, 1970

8）Aurelian L, Strandberg JD, Melendez LV, et al : Herpesvirus type 2 isolated from cervical tumor cells grown in tissue culture. Science 174 : 704-707, 1971

9）Meisels A, Fortin R : Condylomatous lesions of the cervix and vagina. Acta Cytol 20 : 505-509, 1976

10）Syrjanen KJ, Heinenon UM, Kauraniemi T : Cytologic evidence of the association of condylomatous lesions with dysplastic and neoplastic changes in the uterine cervix. Acta Cytol 25 : 17-22, 1981

11）Dürst M, Gissmann L, Ikenberg H, et al : A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad USA 80 : 3812-3815, 1983

12）Scheffner M, Werness BA, Huibregtse JM, et al : The E6 protein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 : 1129-1136, 1990

13）Cullen AP, Reid R, Campion M, et al : Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasia. J Virol 65 : 606, 1991

14）zur Hausen H : Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Seminor Cancer Biol 9 : 405-411, 1999

15）Maehama T, Asato T, Kanazawa K : Prevalence of HPV infection in cervical cytology-normal women in Okinawa, Japan, as determined by a polymerase chain reaction. Int J Obstet Gynecol 69 : 175-176, 2000

16）Ho GY, Bierman R, Beardsley, L, et al : Natural history of cervical human papillomavirus infection in young women. N Eng J Med 338 : 423-428, 1998

17）Winter RL, Lee SK, Hughs JP, et al : Genital human papillomavirus infection : incidence and risk factors in a cohort of female university students. Am J Epidemiol 157 : 218-226, 2003